Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Apr 12, 2016

30071_dirs_2016-04-12_56ffc249-3ddc-4199-957a-cbd1b60a2237.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-04-04

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-04-04 ResMed Common Stock M 20000 $25.54 Acquired 367978 Direct
2016-04-04 ResMed Common Stock S 20000 $58.62 Disposed 347978 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-04 Resmed Stock Option Plan $25.54 M 20000 Disposed 2016-12-17 ResMed Common Stock (20000) Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vested 1/4 per year on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from 58.35 to 58.81. The price reported above represents the weighted average sales price. The reporting person will provide full information about the number of shares and prices at which the transaction was effected, on request, to the SEC staff, the issuer, or the security holder of the issuer.